134 related articles for article (PubMed ID: 18275844)
21. Evidence for a phosphorylation-independent role for Ser 32 and 36 in proteasome inhibitor-resistant (PIR) IkappaBalpha degradation in B cells.
O'Connor S; Markovina S; Miyamoto S
Exp Cell Res; 2005 Jul; 307(1):15-25. PubMed ID: 15922723
[TBL] [Abstract][Full Text] [Related]
22. Protective effect of Ginkgolids (A+B) is associated with inhibition of NIK/IKK/IkappaB/NF-kappaB signaling pathway in a rat model of permanent focal cerebral ischemia.
Wang X; Qin ZH; Shi H; Savitz SI; Qin AP; Jiang Y; Zhang HL
Brain Res; 2008 Oct; 1234():8-15. PubMed ID: 18722355
[TBL] [Abstract][Full Text] [Related]
23. Elevated constitutive IkappaB kinase activity and IkappaB-alpha phosphorylation in Hs294T melanoma cells lead to increased basal MGSA/GRO-alpha transcription.
Devalaraja MN; Wang DZ; Ballard DW; Richmond A
Cancer Res; 1999 Mar; 59(6):1372-7. PubMed ID: 10096573
[TBL] [Abstract][Full Text] [Related]
24. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.
Kauppinen A; Suuronen T; Ojala J; Kaarniranta K; Salminen A
Cell Signal; 2013 Oct; 25(10):1939-48. PubMed ID: 23770291
[TBL] [Abstract][Full Text] [Related]
25. Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo.
Rodriguez MS; Wright J; Thompson J; Thomas D; Baleux F; Virelizier JL; Hay RT; Arenzana-Seisdedos F
Oncogene; 1996 Jun; 12(11):2425-35. PubMed ID: 8649784
[TBL] [Abstract][Full Text] [Related]
26. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
27. Ubiquitin-activating enzyme E1 inhibitor PYR41 attenuates angiotensin II-induced activation of dendritic cells via the IκBa/NF-κB and MKP1/ERK/STAT1 pathways.
Chen C; Meng Y; Wang L; Wang HX; Tian C; Pang GD; Li HH; Du J
Immunology; 2014 Jun; 142(2):307-19. PubMed ID: 24456201
[TBL] [Abstract][Full Text] [Related]
28. A mechanistic insight into a proteasome-independent constitutive inhibitor kappaBalpha (IkappaBalpha) degradation and nuclear factor kappaB (NF-kappaB) activation pathway in WEHI-231 B-cells.
Shumway SD; Miyamoto S
Biochem J; 2004 May; 380(Pt 1):173-80. PubMed ID: 14763901
[TBL] [Abstract][Full Text] [Related]
29. Plant alkaloid tetrandrine downregulates IkappaBalpha kinases-IkappaBalpha-NF-kappaB signaling pathway in human peripheral blood T cell.
Ho LJ; Juan TY; Chao P; Wu WL; Chang DM; Chang SY; Lai JH
Br J Pharmacol; 2004 Dec; 143(7):919-27. PubMed ID: 15504755
[TBL] [Abstract][Full Text] [Related]
30. The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus.
Rothwarf DM; Karin M
Sci STKE; 1999 Oct; 1999(5):RE1. PubMed ID: 11865184
[TBL] [Abstract][Full Text] [Related]
31. Benzoxathiole derivative blocks lipopolysaccharide-induced nuclear factor-kappaB activation and nuclear factor-kappaB-regulated gene transcription through inactivating inhibitory kappaB kinase beta.
Kim BH; Roh E; Lee HY; Lee IJ; Ahn B; Jung SH; Lee H; Han SB; Kim Y
Mol Pharmacol; 2008 Apr; 73(4):1309-18. PubMed ID: 18202307
[TBL] [Abstract][Full Text] [Related]
32. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo.
Krappmann D; Wulczyn FG; Scheidereit C
EMBO J; 1996 Dec; 15(23):6716-26. PubMed ID: 8978697
[TBL] [Abstract][Full Text] [Related]
33. SCF(beta-TRCP) and phosphorylation dependent ubiquitinationof I kappa B alpha catalyzed by Ubc3 and Ubc4.
Strack P; Caligiuri M; Pelletier M; Boisclair M; Theodoras A; Beer-Romero P; Glass S; Parsons T; Copeland RA; Auger KR; Benfield P; Brizuela L; Rolfe M
Oncogene; 2000 Jul; 19(31):3529-36. PubMed ID: 10918611
[TBL] [Abstract][Full Text] [Related]
34. Hit identification of IKKβ natural product inhibitor.
Leung CH; Chan DS; Li YW; Fong WF; Ma DL
BMC Pharmacol Toxicol; 2013 Jan; 14():3. PubMed ID: 23294515
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-1 stimulates cytokines, prostaglandin E2 and matrix metalloproteinase-1 production via activation of MAPK/AP-1 and NF-kappaB in human gingival fibroblasts.
Kida Y; Kobayashi M; Suzuki T; Takeshita A; Okamatsu Y; Hanazawa S; Yasui T; Hasegawa K
Cytokine; 2005 Feb; 29(4):159-68. PubMed ID: 15652448
[TBL] [Abstract][Full Text] [Related]
36. Wortmannin-sensitive pathway is required for insulin-stimulated phosphorylation of inhibitor kappaBalpha.
Pandey SK; He HJ; Chesley A; Juhaszova M; Crow MT; Bernier M
Endocrinology; 2002 Feb; 143(2):375-85. PubMed ID: 11796489
[TBL] [Abstract][Full Text] [Related]
37. A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activity.
Ziegelbauer K; Gantner F; Lukacs NW; Berlin A; Fuchikami K; Niki T; Sakai K; Inbe H; Takeshita K; Ishimori M; Komura H; Murata T; Lowinger T; Bacon KB
Br J Pharmacol; 2005 May; 145(2):178-92. PubMed ID: 15753951
[TBL] [Abstract][Full Text] [Related]
38. Suppression of the NF-kappaB signalling pathway by ergolide, sesquiterpene lactone, in HeLa cells.
Chun JK; Seo DW; Ahn SH; Park JH; You JS; Lee CH; Lee JC; Kim YK; Han JW
J Pharm Pharmacol; 2007 Apr; 59(4):561-6. PubMed ID: 17430640
[TBL] [Abstract][Full Text] [Related]
39. R-Roscovitine simultaneously targets both the p53 and NF-kappaB pathways and causes potentiation of apoptosis: implications in cancer therapy.
Dey A; Wong ET; Cheok CF; Tergaonkar V; Lane DP
Cell Death Differ; 2008 Feb; 15(2):263-73. PubMed ID: 17975552
[TBL] [Abstract][Full Text] [Related]
40. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation.
Sung B; Pandey MK; Aggarwal BB
Mol Pharmacol; 2007 Jun; 71(6):1703-14. PubMed ID: 17387141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
